Biomarker Discovery and Validation ResearchDX
Biomarker Discovery and Validation ResearchDX
Biomarker Discovery and Validation ResearchDX
Diagnostic Development for Precision Medicine

We Build. We Validate. We Deliver.

ResearchDx offers expertise as an integrated start-to-finish partner for Diagnostic Development.
From NGS, RT qPCR, ddPCR to ELISA, Flow and IHC, we bring you the BEST solution to fit your needs.

Regulatory Guidance

Clear Strategic Guidance

ResearchDx supports all types of regulatory submissions.
From Analytic Validation, IDE, 510(k), De Novo, to single site or Full PMA and BIMO.

Assay Comparison

Identify the BEST Solution

From Orthogonal method validation, Multi-site Reproducibility, HEAD-TO-HEAD comparison with
the gold standard, to studies designed to highlight technology/method advantages.

previous arrow
next arrow

We Are With You Every Step of the Way.


We Are With You Every Step of the Way.


No Multi-Partner Outsourcing.

Watch CDO Video

Latest News


This text has been reposted from an earlier press release from INOVIQ Limited. Melbourne, Australia, 8 February 2023: INOVIQ Limited (ASX:IIQ) (INOVIQ or the Company) is pleased to announce positive results from an independent retrospective case-control study to evaluate the performance of its SubB2M-CA15.3 breast cancer test across all stages of breast cancer. Read full […]

Read More

ResearchDx hires Martin Sellers onto their Senior Management team

ResearchDx would like to welcome Martin Sellers as Vice President of Regulatory Affairs!  Sellers’s history has included entrepreneurial ambitions that have brought a record of success in medical device and biotechnology products commercialization. He specialized in bringing novel healthcare products to market in a cost-effective manner, insuring long term profitability upon commercialization for management, investors, […]

Read More

Order now on Science Exchange

Order on Science Exchange